Crossmark

Higher JAK2 V617F mutant allele burden in patients with chronic myeloproliferative neoplasms is associated with a higher prevalence of chronic kidney disease and unfavorable dynamics of kidney function over time

Crossref DOI link: https://doi.org/10.1007/s00277-023-05305-3

Published Online: 2023-06-03

Published Print: 2023-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Lucijanic, Marko https://orcid.org/0000-0002-1372-2040
Veic, Petra

Aric, Ivona

Tupek, Katarina Marija

Soric, Ena

Sabljic, Anica

Vlasac Glasnovic, Josipa

Stoos-Veic, Tajana

Krecak, Ivan

Kusec, Rajko
License Information

Text and Data Mining valid from 2023-06-03

Version of Record valid from 2023-06-03
More Information

Article History

Received: 12 March 2023

Accepted: 27 May 2023

First Online: 3 June 2023

Declarations

:

: The study was approved by the Institutional Review Boards. All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2008.

: All subjects provided written informed consent for molecular analyses.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below